Sanchez, G. A. M. Et Al. 2018. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. JOURNAL OF CLINICAL INVESTIGATION , vol.128, no.7 , 3041-3052.

Sanchez, G. A. M., Reinhardt, A., Ramsey, S., Wittkowski, H., Hashkes, P. J., Berkun, Y., ... Schalm, S.(2018). JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. JOURNAL OF CLINICAL INVESTIGATION , vol.128, no.7, 3041-3052.

Sanchez, Gina Et Al. "JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies," JOURNAL OF CLINICAL INVESTIGATION , vol.128, no.7, 3041-3052, 2018

Sanchez, Gina A. Et Al. "JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies." JOURNAL OF CLINICAL INVESTIGATION , vol.128, no.7, pp.3041-3052, 2018

Sanchez, G. A. M. Et Al. (2018) . "JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies." JOURNAL OF CLINICAL INVESTIGATION , vol.128, no.7, pp.3041-3052.

@article{article, author={Gina A. Montealegre Sanchez Et Al. }, title={JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies}, journal={JOURNAL OF CLINICAL INVESTIGATION}, year=2018, pages={3041-3052} }